Dimercaptosuccinic AcidDMSA (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the Dimercaptosuccinic Acid drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: Dimercaptosuccinic Acid
SUBSTANCE NAME: 2,3-DIMERCAPTOSUCCINIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00


Dimercaptosuccinic Acid DMSA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDimercaptosuccinic Acid DMSA from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1.1(mg/1)
START MARKETING DATE: 2012-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-211_ec657ecb-6327-464c-8aab-6d61a0546b83
PRODUCT NDC: 51808-211
APPLICATION NUMBER:

Other 2,3-DIMERCAPTOSUCCINIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationDimercaptosuccinic Acid
ROTOP Pharmaka GmbHROTOP – DMSA